Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IMS Risk Management Tool Targets "High Risk" MDs: CERTs Conference

Executive Summary

IMS Health is developing a risk management tool that would target "high risk" prescribers for interventions, the company told an April 29-May 1 risk communication workshop.
Advertisement

Related Content

Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs
Drug Risk Assessment Needs IoM Report To Synthesize Research – CERTs
PDUFA III Debate Kicks Off With House Commerce Committee Hearing March 6
FDA Drug Safety Committee Puts CERTs In Central Role
Pfizer “Toolkit” Proposal Focuses On Adverse Event Signals
FDA Sees Risk Management Role For Sales Forces; Drug Safety Cmte. Coming
CERTs Risk Management Agenda Includes Tikosyn Study, Workshops
Roche Accutane Prescriber Registry Added To Pregnancy Prevention Program
Clarification
Postmarketing Surveillance Will Report To Deputy Galson Under CDER Reorg.
Advertisement
UsernamePublicRestriction

Register

PS037869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel